A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Clinical trial NCT05242432 · TERMINATED

Trial details

NCT number: NCT05242432
Sponsor: Janssen Pharmaceutical K.K.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Prevention

Start date: 2022-04-01
Primary completion: 2023-03-20
Enrollment: 2192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.